HEADER HYDROLASE 14-JUN-20 6ZDF TITLE STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ENDO-ALPHA-MANNOSIDASE TITLE 2 MANEA IN COMPLEX WITH HEPES COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOPROTEIN ENDO-ALPHA-1,2-MANNOSIDASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: HENDO,MANDASELIN; COMPND 5 EC: 3.2.1.130; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MANEA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PCOLD-I KEYWDS GOLGI, HYDROLASE, MANNOSIDASE, RETAINING EXPDTA X-RAY DIFFRACTION AUTHOR L.F.SOBALA,P.Z.FERNANDES,Z.HAKKI,A.J.THOMPSON,J.D.HOWE,M.HILL, AUTHOR 2 N.ZITZMANN,S.DAVIES,Z.STAMATAKI,T.D.BUTTERS,D.S.ALONZI,S.J.WILLIAMS, AUTHOR 3 G.J.DAVIES REVDAT 4 24-JAN-24 6ZDF 1 REMARK REVDAT 3 20-JAN-21 6ZDF 1 REMARK REVDAT 2 02-DEC-20 6ZDF 1 JRNL REVDAT 1 18-NOV-20 6ZDF 0 JRNL AUTH L.F.SOBALA,P.Z.FERNANDES,Z.HAKKI,A.J.THOMPSON,J.D.HOWE, JRNL AUTH 2 M.HILL,N.ZITZMANN,S.DAVIES,Z.STAMATAKI,T.D.BUTTERS, JRNL AUTH 3 D.S.ALONZI,S.J.WILLIAMS,G.J.DAVIES JRNL TITL STRUCTURE OF HUMAN ENDO-ALPHA-1,2-MANNOSIDASE (MANEA), AN JRNL TITL 2 ANTIVIRAL HOST-GLYCOSYLATION TARGET. JRNL REF PROC.NATL.ACAD.SCI.USA V. 117 29595 2020 JRNL REFN ESSN 1091-6490 JRNL PMID 33154157 JRNL DOI 10.1073/PNAS.2013620117 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 102.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 30099 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.748 REMARK 3 FREE R VALUE TEST SET COUNT : 1429 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2083 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.3440 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8853 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.31000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : -0.62000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.460 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.871 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.826 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9200 ; 0.012 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12536 ; 1.700 ; 1.647 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1068 ; 5.968 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 516 ;36.265 ;22.093 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1427 ;19.232 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 51 ;17.660 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1143 ; 0.126 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7279 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3957 ; 0.180 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 6154 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 273 ; 0.110 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4281 ; 2.769 ; 4.821 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5346 ; 4.566 ; 7.229 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4919 ; 2.899 ; 4.972 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 7190 ; 4.687 ; 7.379 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 3 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : Chains A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 0 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : Chains A C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 0 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 REMARK 3 NCS GROUP NUMBER : 3 REMARK 3 CHAIN NAMES : Chains B C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 0 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZDF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1292109355. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS 1.8.2-G5331DE77-RELEASE REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30161 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 102.205 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 20.30 REMARK 200 R MERGE (I) : 0.58200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 20.50 REMARK 200 R MERGE FOR SHELL (I) : 1.17500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.17 REMARK 200 STARTING MODEL: 6ZDC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 M SODIUM SUCCINATE PH 7.0, 1% W/V REMARK 280 PEG-MME2000 PROTEIN AT 10 MG/ML IN BUFFER: 25 MM HEPES PH 7.0, REMARK 280 200 MM NACL 100 NL PROTEIN SOLUTION AND 200 NL RESERVOIR REMARK 280 SOLUTION., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.83050 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 72.12250 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 72.12250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 104.74575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 72.12250 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 72.12250 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.91525 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 72.12250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 72.12250 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 104.74575 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 72.12250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 72.12250 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 34.91525 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.83050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 81 REMARK 465 ASN A 82 REMARK 465 HIS A 83 REMARK 465 LYS A 84 REMARK 465 VAL A 85 REMARK 465 HIS A 86 REMARK 465 HIS A 87 REMARK 465 HIS A 88 REMARK 465 HIS A 89 REMARK 465 HIS A 90 REMARK 465 HIS A 91 REMARK 465 ILE A 92 REMARK 465 GLU A 93 REMARK 465 GLY A 94 REMARK 465 ARG A 95 REMARK 465 HIS A 96 REMARK 465 MET A 97 REMARK 465 PRO A 98 REMARK 465 LEU A 455 REMARK 465 ASP A 456 REMARK 465 ARG A 457 REMARK 465 GLN A 458 REMARK 465 LEU A 459 REMARK 465 PRO A 460 REMARK 465 VAL A 461 REMARK 465 SER A 462 REMARK 465 MET B 81 REMARK 465 ASN B 82 REMARK 465 HIS B 83 REMARK 465 LYS B 84 REMARK 465 VAL B 85 REMARK 465 HIS B 86 REMARK 465 HIS B 87 REMARK 465 HIS B 88 REMARK 465 HIS B 89 REMARK 465 HIS B 90 REMARK 465 HIS B 91 REMARK 465 ILE B 92 REMARK 465 GLU B 93 REMARK 465 GLY B 94 REMARK 465 ARG B 95 REMARK 465 HIS B 96 REMARK 465 MET B 97 REMARK 465 LEU B 455 REMARK 465 ASP B 456 REMARK 465 ARG B 457 REMARK 465 GLN B 458 REMARK 465 LEU B 459 REMARK 465 PRO B 460 REMARK 465 VAL B 461 REMARK 465 SER B 462 REMARK 465 MET C 81 REMARK 465 ASN C 82 REMARK 465 HIS C 83 REMARK 465 LYS C 84 REMARK 465 VAL C 85 REMARK 465 HIS C 86 REMARK 465 HIS C 87 REMARK 465 HIS C 88 REMARK 465 HIS C 89 REMARK 465 HIS C 90 REMARK 465 HIS C 91 REMARK 465 ILE C 92 REMARK 465 GLU C 93 REMARK 465 GLY C 94 REMARK 465 ARG C 95 REMARK 465 HIS C 96 REMARK 465 LEU C 455 REMARK 465 ASP C 456 REMARK 465 ARG C 457 REMARK 465 GLN C 458 REMARK 465 LEU C 459 REMARK 465 PRO C 460 REMARK 465 VAL C 461 REMARK 465 SER C 462 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 307 CE NZ REMARK 470 SER A 420 OG REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 LYS B 307 CE NZ REMARK 470 SER B 420 OG REMARK 470 LYS C 119 CE NZ REMARK 470 LYS C 137 CG CD CE NZ REMARK 470 LYS C 307 CE NZ REMARK 470 SER C 420 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 122 -44.99 71.12 REMARK 500 LEU A 128 100.83 58.55 REMARK 500 PRO A 133 -30.70 -38.62 REMARK 500 ARG A 288 53.19 -116.99 REMARK 500 TYR A 323 -68.94 52.40 REMARK 500 ASN A 369 45.28 -77.25 REMARK 500 ASN A 403 52.25 -145.77 REMARK 500 THR A 419 -166.59 -128.20 REMARK 500 ASN A 421 14.92 -151.63 REMARK 500 LEU B 99 -168.35 -76.82 REMARK 500 HIS B 122 -43.48 71.29 REMARK 500 LEU B 128 103.80 60.48 REMARK 500 ARG B 288 51.65 -115.11 REMARK 500 TYR B 323 -69.13 52.02 REMARK 500 ASN B 369 45.30 -77.91 REMARK 500 ASN B 403 52.31 -146.00 REMARK 500 THR B 419 -165.64 -127.48 REMARK 500 LEU C 99 -151.78 53.93 REMARK 500 ASN C 100 104.53 -165.78 REMARK 500 HIS C 122 -43.41 70.81 REMARK 500 LEU C 128 101.72 59.86 REMARK 500 ARG C 288 52.42 -115.63 REMARK 500 TYR C 323 -69.34 52.02 REMARK 500 ASN C 369 45.12 -78.29 REMARK 500 ASN C 403 52.05 -146.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EPE A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EPE B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EPE C 501 DBREF 6ZDF A 98 462 UNP Q5SRI9 MANEA_HUMAN 98 462 DBREF 6ZDF B 98 462 UNP Q5SRI9 MANEA_HUMAN 98 462 DBREF 6ZDF C 98 462 UNP Q5SRI9 MANEA_HUMAN 98 462 SEQADV 6ZDF MET A 81 UNP Q5SRI9 INITIATING METHIONINE SEQADV 6ZDF ASN A 82 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 83 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF LYS A 84 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF VAL A 85 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 86 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 87 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 88 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 89 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 90 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 91 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF ILE A 92 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF GLU A 93 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF GLY A 94 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF ARG A 95 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS A 96 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF MET A 97 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF MET B 81 UNP Q5SRI9 INITIATING METHIONINE SEQADV 6ZDF ASN B 82 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 83 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF LYS B 84 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF VAL B 85 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 86 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 87 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 88 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 89 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 90 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 91 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF ILE B 92 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF GLU B 93 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF GLY B 94 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF ARG B 95 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS B 96 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF MET B 97 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF MET C 81 UNP Q5SRI9 INITIATING METHIONINE SEQADV 6ZDF ASN C 82 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 83 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF LYS C 84 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF VAL C 85 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 86 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 87 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 88 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 89 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 90 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 91 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF ILE C 92 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF GLU C 93 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF GLY C 94 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF ARG C 95 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF HIS C 96 UNP Q5SRI9 EXPRESSION TAG SEQADV 6ZDF MET C 97 UNP Q5SRI9 EXPRESSION TAG SEQRES 1 A 382 MET ASN HIS LYS VAL HIS HIS HIS HIS HIS HIS ILE GLU SEQRES 2 A 382 GLY ARG HIS MET PRO LEU ASN ASN TYR LEU HIS VAL PHE SEQRES 3 A 382 TYR TYR SER TRP TYR GLY ASN PRO GLN PHE ASP GLY LYS SEQRES 4 A 382 TYR ILE HIS TRP ASN HIS PRO VAL LEU GLU HIS TRP ASP SEQRES 5 A 382 PRO ARG ILE ALA LYS ASN TYR PRO GLN GLY ARG HIS ASN SEQRES 6 A 382 PRO PRO ASP ASP ILE GLY SER SER PHE TYR PRO GLU LEU SEQRES 7 A 382 GLY SER TYR SER SER ARG ASP PRO SER VAL ILE GLU THR SEQRES 8 A 382 HIS MET ARG GLN MET ARG SER ALA SER ILE GLY VAL LEU SEQRES 9 A 382 ALA LEU SER TRP TYR PRO PRO ASP VAL ASN ASP GLU ASN SEQRES 10 A 382 GLY GLU PRO THR ASP ASN LEU VAL PRO THR ILE LEU ASP SEQRES 11 A 382 LYS ALA HIS LYS TYR ASN LEU LYS VAL THR PHE HIS ILE SEQRES 12 A 382 GLU PRO TYR SER ASN ARG ASP ASP GLN ASN MET TYR LYS SEQRES 13 A 382 ASN VAL LYS TYR ILE ILE ASP LYS TYR GLY ASN HIS PRO SEQRES 14 A 382 ALA PHE TYR ARG TYR LYS THR LYS THR GLY ASN ALA LEU SEQRES 15 A 382 PRO MET PHE TYR VAL TYR ASP SER TYR ILE THR LYS PRO SEQRES 16 A 382 GLU LYS TRP ALA ASN LEU LEU THR THR SER GLY SER ARG SEQRES 17 A 382 SER ILE ARG ASN SER PRO TYR ASP GLY LEU PHE ILE ALA SEQRES 18 A 382 LEU LEU VAL GLU GLU LYS HIS LYS TYR ASP ILE LEU GLN SEQRES 19 A 382 SER GLY PHE ASP GLY ILE TYR THR TYR PHE ALA THR ASN SEQRES 20 A 382 GLY PHE THR TYR GLY SER SER HIS GLN ASN TRP ALA SER SEQRES 21 A 382 LEU LYS LEU PHE CYS ASP LYS TYR ASN LEU ILE PHE ILE SEQRES 22 A 382 PRO SER VAL GLY PRO GLY TYR ILE ASP THR SER ILE ARG SEQRES 23 A 382 PRO TRP ASN THR GLN ASN THR ARG ASN ARG ILE ASN GLY SEQRES 24 A 382 LYS TYR TYR GLU ILE GLY LEU SER ALA ALA LEU GLN THR SEQRES 25 A 382 ARG PRO SER LEU ILE SER ILE THR SER PHE ASN GLU TRP SEQRES 26 A 382 HIS GLU GLY THR GLN ILE GLU LYS ALA VAL PRO LYS ARG SEQRES 27 A 382 THR SER ASN THR VAL TYR LEU ASP TYR ARG PRO HIS LYS SEQRES 28 A 382 PRO GLY LEU TYR LEU GLU LEU THR ARG LYS TRP SER GLU SEQRES 29 A 382 LYS TYR SER LYS GLU ARG ALA THR TYR ALA LEU ASP ARG SEQRES 30 A 382 GLN LEU PRO VAL SER SEQRES 1 B 382 MET ASN HIS LYS VAL HIS HIS HIS HIS HIS HIS ILE GLU SEQRES 2 B 382 GLY ARG HIS MET PRO LEU ASN ASN TYR LEU HIS VAL PHE SEQRES 3 B 382 TYR TYR SER TRP TYR GLY ASN PRO GLN PHE ASP GLY LYS SEQRES 4 B 382 TYR ILE HIS TRP ASN HIS PRO VAL LEU GLU HIS TRP ASP SEQRES 5 B 382 PRO ARG ILE ALA LYS ASN TYR PRO GLN GLY ARG HIS ASN SEQRES 6 B 382 PRO PRO ASP ASP ILE GLY SER SER PHE TYR PRO GLU LEU SEQRES 7 B 382 GLY SER TYR SER SER ARG ASP PRO SER VAL ILE GLU THR SEQRES 8 B 382 HIS MET ARG GLN MET ARG SER ALA SER ILE GLY VAL LEU SEQRES 9 B 382 ALA LEU SER TRP TYR PRO PRO ASP VAL ASN ASP GLU ASN SEQRES 10 B 382 GLY GLU PRO THR ASP ASN LEU VAL PRO THR ILE LEU ASP SEQRES 11 B 382 LYS ALA HIS LYS TYR ASN LEU LYS VAL THR PHE HIS ILE SEQRES 12 B 382 GLU PRO TYR SER ASN ARG ASP ASP GLN ASN MET TYR LYS SEQRES 13 B 382 ASN VAL LYS TYR ILE ILE ASP LYS TYR GLY ASN HIS PRO SEQRES 14 B 382 ALA PHE TYR ARG TYR LYS THR LYS THR GLY ASN ALA LEU SEQRES 15 B 382 PRO MET PHE TYR VAL TYR ASP SER TYR ILE THR LYS PRO SEQRES 16 B 382 GLU LYS TRP ALA ASN LEU LEU THR THR SER GLY SER ARG SEQRES 17 B 382 SER ILE ARG ASN SER PRO TYR ASP GLY LEU PHE ILE ALA SEQRES 18 B 382 LEU LEU VAL GLU GLU LYS HIS LYS TYR ASP ILE LEU GLN SEQRES 19 B 382 SER GLY PHE ASP GLY ILE TYR THR TYR PHE ALA THR ASN SEQRES 20 B 382 GLY PHE THR TYR GLY SER SER HIS GLN ASN TRP ALA SER SEQRES 21 B 382 LEU LYS LEU PHE CYS ASP LYS TYR ASN LEU ILE PHE ILE SEQRES 22 B 382 PRO SER VAL GLY PRO GLY TYR ILE ASP THR SER ILE ARG SEQRES 23 B 382 PRO TRP ASN THR GLN ASN THR ARG ASN ARG ILE ASN GLY SEQRES 24 B 382 LYS TYR TYR GLU ILE GLY LEU SER ALA ALA LEU GLN THR SEQRES 25 B 382 ARG PRO SER LEU ILE SER ILE THR SER PHE ASN GLU TRP SEQRES 26 B 382 HIS GLU GLY THR GLN ILE GLU LYS ALA VAL PRO LYS ARG SEQRES 27 B 382 THR SER ASN THR VAL TYR LEU ASP TYR ARG PRO HIS LYS SEQRES 28 B 382 PRO GLY LEU TYR LEU GLU LEU THR ARG LYS TRP SER GLU SEQRES 29 B 382 LYS TYR SER LYS GLU ARG ALA THR TYR ALA LEU ASP ARG SEQRES 30 B 382 GLN LEU PRO VAL SER SEQRES 1 C 382 MET ASN HIS LYS VAL HIS HIS HIS HIS HIS HIS ILE GLU SEQRES 2 C 382 GLY ARG HIS MET PRO LEU ASN ASN TYR LEU HIS VAL PHE SEQRES 3 C 382 TYR TYR SER TRP TYR GLY ASN PRO GLN PHE ASP GLY LYS SEQRES 4 C 382 TYR ILE HIS TRP ASN HIS PRO VAL LEU GLU HIS TRP ASP SEQRES 5 C 382 PRO ARG ILE ALA LYS ASN TYR PRO GLN GLY ARG HIS ASN SEQRES 6 C 382 PRO PRO ASP ASP ILE GLY SER SER PHE TYR PRO GLU LEU SEQRES 7 C 382 GLY SER TYR SER SER ARG ASP PRO SER VAL ILE GLU THR SEQRES 8 C 382 HIS MET ARG GLN MET ARG SER ALA SER ILE GLY VAL LEU SEQRES 9 C 382 ALA LEU SER TRP TYR PRO PRO ASP VAL ASN ASP GLU ASN SEQRES 10 C 382 GLY GLU PRO THR ASP ASN LEU VAL PRO THR ILE LEU ASP SEQRES 11 C 382 LYS ALA HIS LYS TYR ASN LEU LYS VAL THR PHE HIS ILE SEQRES 12 C 382 GLU PRO TYR SER ASN ARG ASP ASP GLN ASN MET TYR LYS SEQRES 13 C 382 ASN VAL LYS TYR ILE ILE ASP LYS TYR GLY ASN HIS PRO SEQRES 14 C 382 ALA PHE TYR ARG TYR LYS THR LYS THR GLY ASN ALA LEU SEQRES 15 C 382 PRO MET PHE TYR VAL TYR ASP SER TYR ILE THR LYS PRO SEQRES 16 C 382 GLU LYS TRP ALA ASN LEU LEU THR THR SER GLY SER ARG SEQRES 17 C 382 SER ILE ARG ASN SER PRO TYR ASP GLY LEU PHE ILE ALA SEQRES 18 C 382 LEU LEU VAL GLU GLU LYS HIS LYS TYR ASP ILE LEU GLN SEQRES 19 C 382 SER GLY PHE ASP GLY ILE TYR THR TYR PHE ALA THR ASN SEQRES 20 C 382 GLY PHE THR TYR GLY SER SER HIS GLN ASN TRP ALA SER SEQRES 21 C 382 LEU LYS LEU PHE CYS ASP LYS TYR ASN LEU ILE PHE ILE SEQRES 22 C 382 PRO SER VAL GLY PRO GLY TYR ILE ASP THR SER ILE ARG SEQRES 23 C 382 PRO TRP ASN THR GLN ASN THR ARG ASN ARG ILE ASN GLY SEQRES 24 C 382 LYS TYR TYR GLU ILE GLY LEU SER ALA ALA LEU GLN THR SEQRES 25 C 382 ARG PRO SER LEU ILE SER ILE THR SER PHE ASN GLU TRP SEQRES 26 C 382 HIS GLU GLY THR GLN ILE GLU LYS ALA VAL PRO LYS ARG SEQRES 27 C 382 THR SER ASN THR VAL TYR LEU ASP TYR ARG PRO HIS LYS SEQRES 28 C 382 PRO GLY LEU TYR LEU GLU LEU THR ARG LYS TRP SER GLU SEQRES 29 C 382 LYS TYR SER LYS GLU ARG ALA THR TYR ALA LEU ASP ARG SEQRES 30 C 382 GLN LEU PRO VAL SER HET EPE A 501 15 HET EPE B 501 15 HET EPE C 501 15 HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN EPE HEPES FORMUL 4 EPE 3(C8 H18 N2 O4 S) FORMUL 7 HOH *140(H2 O) HELIX 1 AA1 ASP A 132 LYS A 137 1 6 HELIX 2 AA2 ASP A 165 SER A 178 1 14 HELIX 3 AA3 ASN A 203 TYR A 215 1 13 HELIX 4 AA4 ASP A 230 GLY A 246 1 17 HELIX 5 AA5 ASP A 269 THR A 273 5 5 HELIX 6 AA6 LYS A 274 THR A 283 1 10 HELIX 7 AA7 LYS A 307 GLY A 316 1 10 HELIX 8 AA8 SER A 334 GLN A 336 5 3 HELIX 9 AA9 ASN A 337 TYR A 348 1 12 HELIX 10 AB1 TRP A 368 THR A 373 5 6 HELIX 11 AB2 GLY A 379 GLN A 391 1 13 HELIX 12 AB3 GLY A 433 ALA A 451 1 19 HELIX 13 AB4 ASP B 132 LYS B 137 1 6 HELIX 14 AB5 ASP B 165 SER B 178 1 14 HELIX 15 AB6 ASN B 203 TYR B 215 1 13 HELIX 16 AB7 ASP B 230 GLY B 246 1 17 HELIX 17 AB8 ASP B 269 THR B 273 5 5 HELIX 18 AB9 LYS B 274 THR B 283 1 10 HELIX 19 AC1 LYS B 307 GLY B 316 1 10 HELIX 20 AC2 SER B 334 GLN B 336 5 3 HELIX 21 AC3 ASN B 337 TYR B 348 1 12 HELIX 22 AC4 TRP B 368 THR B 373 5 6 HELIX 23 AC5 ARG B 376 ASN B 378 5 3 HELIX 24 AC6 GLY B 379 GLN B 391 1 13 HELIX 25 AC7 GLY B 433 ALA B 451 1 19 HELIX 26 AC8 ASP C 132 LYS C 137 1 6 HELIX 27 AC9 ASP C 165 SER C 178 1 14 HELIX 28 AD1 ASN C 203 TYR C 215 1 13 HELIX 29 AD2 ASP C 230 GLY C 246 1 17 HELIX 30 AD3 ASP C 269 THR C 273 5 5 HELIX 31 AD4 LYS C 274 THR C 283 1 10 HELIX 32 AD5 LYS C 307 GLY C 316 1 10 HELIX 33 AD6 SER C 334 GLN C 336 5 3 HELIX 34 AD7 ASN C 337 TYR C 348 1 12 HELIX 35 AD8 TRP C 368 THR C 373 5 6 HELIX 36 AD9 ARG C 376 ASN C 378 5 3 HELIX 37 AE1 GLY C 379 GLN C 391 1 13 HELIX 38 AE2 GLY C 433 ALA C 451 1 19 SHEET 1 AA1 5 ARG A 253 LYS A 255 0 SHEET 2 AA1 5 ALA A 261 VAL A 267 -1 O LEU A 262 N TYR A 254 SHEET 3 AA1 5 LEU A 298 LEU A 302 1 O ILE A 300 N PHE A 265 SHEET 4 AA1 5 GLY A 319 TYR A 321 1 O GLY A 319 N ALA A 301 SHEET 5 AA1 5 ILE A 351 ILE A 353 1 O ILE A 353 N ILE A 320 SHEET 1 AA2 7 ARG A 253 LYS A 255 0 SHEET 2 AA2 7 ALA A 261 VAL A 267 -1 O LEU A 262 N TYR A 254 SHEET 3 AA2 7 LYS A 218 ILE A 223 1 N ILE A 223 O TYR A 266 SHEET 4 AA2 7 ILE A 181 TRP A 188 1 N LEU A 186 O HIS A 222 SHEET 5 AA2 7 ASN A 100 TYR A 107 1 N VAL A 105 O ALA A 185 SHEET 6 AA2 7 ILE A 397 ILE A 399 1 O ILE A 397 N HIS A 104 SHEET 7 AA2 7 SER A 355 VAL A 356 1 N VAL A 356 O SER A 398 SHEET 1 AA3 5 ARG B 253 LYS B 255 0 SHEET 2 AA3 5 ALA B 261 VAL B 267 -1 O LEU B 262 N TYR B 254 SHEET 3 AA3 5 LEU B 298 LEU B 302 1 O ILE B 300 N PHE B 265 SHEET 4 AA3 5 GLY B 319 TYR B 321 1 O GLY B 319 N ALA B 301 SHEET 5 AA3 5 ILE B 351 ILE B 353 1 O ILE B 353 N ILE B 320 SHEET 1 AA4 7 ARG B 253 LYS B 255 0 SHEET 2 AA4 7 ALA B 261 VAL B 267 -1 O LEU B 262 N TYR B 254 SHEET 3 AA4 7 LYS B 218 ILE B 223 1 N ILE B 223 O TYR B 266 SHEET 4 AA4 7 VAL B 183 TRP B 188 1 N LEU B 186 O HIS B 222 SHEET 5 AA4 7 LEU B 103 TYR B 107 1 N VAL B 105 O ALA B 185 SHEET 6 AA4 7 ILE B 397 ILE B 399 1 O ILE B 397 N HIS B 104 SHEET 7 AA4 7 SER B 355 VAL B 356 1 N VAL B 356 O SER B 398 SHEET 1 AA5 5 ARG C 253 LYS C 255 0 SHEET 2 AA5 5 ALA C 261 VAL C 267 -1 O LEU C 262 N TYR C 254 SHEET 3 AA5 5 LEU C 298 LEU C 302 1 O ILE C 300 N PHE C 265 SHEET 4 AA5 5 GLY C 319 TYR C 321 1 O GLY C 319 N ALA C 301 SHEET 5 AA5 5 ILE C 351 ILE C 353 1 O ILE C 353 N ILE C 320 SHEET 1 AA6 7 ARG C 253 LYS C 255 0 SHEET 2 AA6 7 ALA C 261 VAL C 267 -1 O LEU C 262 N TYR C 254 SHEET 3 AA6 7 LYS C 218 ILE C 223 1 N ILE C 223 O TYR C 266 SHEET 4 AA6 7 VAL C 183 TRP C 188 1 N LEU C 186 O HIS C 222 SHEET 5 AA6 7 LEU C 103 TYR C 107 1 N VAL C 105 O ALA C 185 SHEET 6 AA6 7 ILE C 397 ILE C 399 1 O ILE C 397 N HIS C 104 SHEET 7 AA6 7 SER C 355 VAL C 356 1 N VAL C 356 O SER C 398 CISPEP 1 PRO A 146 PRO A 147 0 13.61 CISPEP 2 THR A 400 SER A 401 0 0.88 CISPEP 3 ARG A 428 PRO A 429 0 15.35 CISPEP 4 PRO B 146 PRO B 147 0 14.66 CISPEP 5 THR B 400 SER B 401 0 0.78 CISPEP 6 ARG B 428 PRO B 429 0 15.09 CISPEP 7 PRO C 146 PRO C 147 0 14.76 CISPEP 8 THR C 400 SER C 401 0 0.36 CISPEP 9 ARG C 428 PRO C 429 0 14.95 SITE 1 AC1 6 TYR A 108 TYR A 189 ASP A 195 GLU A 196 SITE 2 AC1 6 HIS A 222 GLU A 224 SITE 1 AC2 7 TYR B 108 TYR B 189 ASP B 195 GLU B 196 SITE 2 AC2 7 HIS B 222 GLU B 224 TYR B 268 SITE 1 AC3 7 TYR C 108 TYR C 189 GLU C 196 HIS C 222 SITE 2 AC3 7 GLU C 224 TYR C 268 TYR C 323 CRYST1 144.245 144.245 139.661 90.00 90.00 90.00 P 43 21 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006933 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006933 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007160 0.00000